SIP
Click for more information
1.55% $1.31 sigma pharmaceuticals limited

any whispers as to who the suitor is?, page-4

  1. hannahgrace
    644 Posts.
    lightbulb Created with Sketch. 1
    clock Created with Sketch.
    21/05/10
    16:35
    Post #: 6723067
    Or:

    Aspen, Ranbaxy behind bid for Sigma Pharmaceuticals
    UPDATE: John Durie From: The Australian May 21, 2010 3:08PM

    THE Sigma bidder remains a mystery but market speculation has centred on two offshore trade buyers, Aspen Pharma, based in South Africa, and India-based Ranbaxy, with the odds favouring the former.
    SIP Price at posting: 48.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

JBH JB Hi-Fi reports $9.59 billion in sales for FY 2024, snaffles home retailer E & S Trading Co
right-arrow Created with Sketch.
FBU Fletcher Building sells Tradelink for $170M, says plumbing division "not a natural fit"
right-arrow Created with Sketch.
WAF Drilling at Kiaka Gold Project yields 7.6 g/t intercept for West African
right-arrow Created with Sketch.
BPT Beach Energy profits fall -11% in FY24 on back of higher costs in Cooper Basin
right-arrow Created with Sketch.
STX Award of 85 MW capacity pushes Strike's Erregulla power station project closer to FID
right-arrow Created with Sketch.
AVR Anteris the latest to flee a struggling ASX for Wall Street's NASDAQ
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SIP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.